Sumitomo Mitsui DS Asset Management Company, Ltd
Position in INSM — INSMED Inc
CIK 1411530
TOKYO, M0
Position in INSM
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,377,945
-$1,269,041 QoQ
Shares Held
22,303
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#273
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui DS Asset Management Company, Ltd holds $66,797,123 across 9 Biotechnology names. INSM ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
63,330 | $31,457,910 | |
| 2 | RPRX |
Royalty Pharma plc
|
206,765 | $11,593,313 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,260 | $8,891,680 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
18,366 | $5,528,716 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
17,140 | $3,209,979 | |
| 6 | INCY |
Incyte Corp
|
23,037 | $2,611,474 | |
| 7 | INSM |
INSMED Inc
This page
|
22,303 | $2,377,945 | |
| 8 | MRNA |
Moderna, Inc.
|
11,938 | $836,018 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,377,945 | 22,303 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $3,646,986 | 22,303 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,881,614 | 22,303 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||